期刊文献+

舌癌耐药细胞株的建立及癌干细胞特性的实验观察 被引量:2

Establishment of a drug-resistant tongue cancer cell line and analysis of its cancer stem cell characteristics
下载PDF
导出
摘要 目的建立舌癌耐药细胞株,并观察耐药细胞株癌干细胞的相关生物学特性。方法以低浓度阿霉素持续增量诱导法建立TCA-8113舌癌耐药细胞株,并对亲代与舌癌耐药细胞株进行癌细胞基本特性、癌干细胞相关细胞学特性的检测,分别以计数法检测癌细胞生长曲线、倍增时间以及用MTT法测定耐药倍数,并进行单个细胞成克隆实验、平板克隆形成实验和悬浮球形成实验。结果 TCA-8113舌癌耐药细胞为"铺路石"状上皮样生长方式,但其中异形细胞略多,耐药倍数为22倍;生长曲线提示其增殖速度明显低于亲本TCA-8113舌癌细胞,且倍增时间增加,但在细胞周期中各期细胞比例未见明显改变;TCA-8113舌癌耐药细胞克隆形成率、单个细胞培养成株率均明显低于其亲本TCA-8113舌癌细胞(P﹤0.05)。结论低浓度阿霉素持续增量法可诱导形成舌癌耐药细胞株,但舌癌耐药细胞株的癌干细胞特征并不明显。 Objective To establish a drug-resistant tongue cancer cell line and analyze its cancer stern cell (CSC)characteristics. Methods Tongue cancer cell line TCA-8113 was induced by adriamycin (ADM)and used to establish the drug-resistant cell line TCA-8113/ADM.Basic characteristics of both the parental cell line TCA-8113 and the drug-resistant cell line TCA-8113/ADM were analyzed and compared, including cell growth, doubling time, cell cycle, resistance index( RI ), single-cell culture, colony formation and formation of sphere cells. Results The growth pattern of TCA-8113/ADM cells was cobblestone-like, with cultures showing sig- nificantly more atypical cells than those of parental cells.TCA-8113/ADM cells had an RI of 22, and their rates of cell proliferation, cell doubling, colony formation and sphere cell formation were slower than those of the parental cells. Conclusion Sustained incremental exposure to low concentrations of ADM can induce a drug-resistant tongue cancer cell line,but its CSC characteristics are not obvious.
出处 《中国癌症防治杂志》 CAS 2012年第2期170-173,共4页 CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
基金 国家自然科学基金资助项目(30860326) 广西自然科学基金资助项目(0991139) 广西科技创新能力与条件建设项目(桂科攻0993003C-1)
关键词 舌癌 耐药细胞 癌干细胞 耐药诱导 特性 Tongue cancer Drug-resistant Cancer stem cell Drug-resistant inducement Characteristic
  • 相关文献

参考文献2

二级参考文献44

  • 1程磊,周梁.肿瘤干细胞的研究进展[J].肿瘤,2006,26(7):688-690. 被引量:6
  • 2REYA T, MORRISON S J, CLARKE M F, et al. Stem cells, cancer, and cancer stem ceils [J]. Nature, 2001, 414 (6859) : 105-111.
  • 3WANG J, GUO L P, CHEN L Z, et al. Identification of cancer stem cell like side population cells in human nasopharyngeal carcinoma cell line[J]. Cancer Res, 2007,67(8) :3716-3724.
  • 4HILL R P. Identifying cancer stem cells in solid tumors: case not proven [ J ]. Cancer Res, 2006,66 ( 4 ) : 1891-1895.
  • 5YIN S, LI J, HU C, et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity [ J ]. Int J Cancer, 2007,120(7) : 1444-1450.
  • 6BEIER D, HAU P, PROESCHOLDT M, et al. CD133^+ and CD133^- glioblastoma-defived cancer stem cells show differential growth characteristics and molecular profiles [ J ]. Cancer Res, 2007, 67(9) : 4010-4015.
  • 7KUSUHARA H, SUGIYAMA Y. ATP-binding cassette, subfamily G (ABCG family) [J]. Pflugers Arch, 2007,453(5) :735-744.
  • 8LOU H, DEAN M. Targeted therapy for cancer stem cells: the patched pathway and ABC transporters [ J ]. Oncogene, 2007,26 (9) : 1357-1360.
  • 9SARKADI B, HOMOLYA L, SZAKACS G, et al. Human multidrug resistance ABCG transporters : participation in a chemoimmunity defense system[J]. Physiol Rev, 2006,86(4) : 1179-1236.
  • 10CHIBA T, KITA K, ZHENG YW, et al. Side population purified from hepatoeellular eareinorna cells harbors eaneer stem cell-like properties[J]. Hepatology, 2006,44( 1 ) : 240 251.

共引文献20

同被引文献18

  • 1杨波,谭颖徽,张建设.顺铂诱导人口腔癌ACCM细胞耐药形成[J].西南国防医药,2004,14(3):260-263. 被引量:1
  • 2邝晓聪,温冠媚,蔡捷,李俊,姚金光.舌癌转移淋巴结中舌癌细胞耐药性的实验研究[J].中华肿瘤防治杂志,2007,14(21):1617-1619. 被引量:2
  • 3张志愿.口腔颌面外科学[M].7版.北京:人民卫生出版社,2012:471.
  • 4Mignogna MD, Felele S, Russo LL. The world cancer report and the burden of oral cancer[J]. Eur J Cancer Prev0 2004, 13 (2) : 139- 142.
  • 5Mochizuki S, Okada Y. ADAMs in cancer cell proliferation and pro- gression [ J ]. Cancer Sci, 2007,98 (5) :621-628.
  • 6Duffy MJ, Muilooly M, O' Donovan N, et al. The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer[J] ? Clin Proteomics, 2011,8( 1 ) :9.
  • 7Yang JM, Xu Z, Wu H, et al. Overexpression of extracellular matrix metalloproteinase inducer in muhidmg resistant cancer cells[ Jl - Mol Cancer Res, 2003,1 (6) :420427.
  • 8Schutz A, Hartig W, Wobus M, et al. Expression of ADAM15 in lung carcinomas [ J ]. Virchows Arch, 2005,446 (4) :421-429.
  • 9Arribas J, Beeh-Serra JJ, Santiago-Josefat B. ADAMs, cell migra- tion and eancer[J]. Cancer Metastasis Rev, 2006,25 ( 1 ) :57-68.
  • 10Lueas N, Day ML. The role of lhe disintegrin metallol.'olei.as: ADAM15 in prostate cancer progression[J]. ,J Cell Bio(:hem, 2009,106 (6) : 967-974.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部